Objective. To develop and assess the psychometric properties of the Localized Scleroderma
(LS) Skin Damage Index (LoSDI) and Physician Global Assessment of disease Damage (…

Objective Juvenile localized scleroderma (LS) is a chronic inflammatory skin disorder
associated with substantial morbidity and disability. Although a wide range of therapeutic …

Objective. To develop and evaluate a Localized Scleroderma (LS) Skin Severity Index (LoSSI)
and global assessments’ clinimetric property and effect on quality of life (QOL). Methods. …

Localized scleroderma (LS) is a disfiguring autoimmune disease of the skin and underlying
tissue that mainly affects the pediatric population. Inflammation of the tissue leads to fibrosis …

Background Lack of agreement on how to accurately capture disease outcomes in localized
scleroderma (LS) has hindered the development of efficacious treatment protocols. The LS …

The term scleroderma literally means “skleros,” sclerosing or hardening, of the “derma,” skin.“Scleroderma”
encompasses both forms of the disease: systemic sclerosis (SSc), …

Objective. To evaluate the effectiveness of a uniform single-center treatment protocol
composed of high-dose methotrexate (MTX) and oral corticosteroids in a pediatric localized …

Localized scleroderma (LS) is a complex disease characterized by a mixture of
inflammation and fibrosis of the skin that, especially in the pediatric population, also affects …

… Author links open overlay panel Kathryn S. Torok MD a b , Katherine Kurzinski a , Christina
Kelsey MSEd a , Jonathan Yabes PhD c d , Kelsey Magee a , Abbe N. Vallejo PhD a b , …

Objectives To determine the reliability and validity of a new measure of finger motion in
patients with systemic sclerosis (SSc), the ‘delta finger-to-palm’(delta FTP) and compare its …